Clinical Data, Inc. (New) (CLDA)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: LABORATORY ANALYTICAL INSTRUMENTS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

ONE GATEWAY CENTER NEWTON, MA 02458

Clinical Data, through its main operating business, PGxHealth, LLC, is focused on the development and commercialization of novel therapeutics, with two lead compounds in the areas of central nervous system and cardiovascular disorders. Co.'s lead drug candidate is vilazodone, for the treatment of depression. Co.'s second late-stage drug candidate is apadenoson, trademarked Stedivaze, for use as a pharmacologic stress agent in nuclear-Single Photo Emission Computed Topography myocardial perfusion imaging. Co. also provides the FAMILION family of genetic tests for inherited cardiac syndromes, including cardiac channelopathies and cardiomyopathies.

View SEC Filings from CLDA instead.

View recent insider trading info

Funds Holding CLDA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLDA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BELBEL CAESAR J EVP, CHIEF LEGAL OFFICER

  • Officer
No longer subject to file 2011-04-13 0

SOBEL BURTON E

  • Director
No longer subject to file 2011-04-13 0

SOLOMON HOWARD PRESIDENT

  • Officer
  • Director
0 2011-04-13 0

FRANCIS PERIER I JR VICE PRESIDENT

  • Officer
0 2011-04-13 0

SOLOMON DAVID F VICE PRESIDENT

  • Officer
  • Director
0 2011-04-13 0

WEINBERGER RITA SECRETARY

  • Officer
0 2011-04-13 0

FOREST LABORATORIES INC

FL HOLDING C.V.

FLI INTERNATIONAL, LLC

DOGWOOD HOLDING CORP.

MAGNOLIA ACQUISITION CORP.

  • 10% Owner
No longer subject to file 2011-04-12 0

KIRK RANDAL J

  • Director
  • 10% Owner
0 2011-04-12 0

HORNER LARRY D /FA

  • Director
No longer subject to file 2011-04-12 0

MALMAN ARTHUR B

  • Director
No longer subject to file 2011-04-12 0

FROMKIN DREW J CEO, PRESIDENT

  • Officer
  • Director
No longer subject to file 2011-04-12 0

WALLACE RICHARD JOHN

  • Director
No longer subject to file 2011-04-12 0

BALLANTYNE CHARLES EVAN EVP, CFO

  • Officer
No longer subject to file 2011-04-12 0

REED CAROL EVP AND CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2011-04-12 0

TARRIFF SCOTT

  • Director
No longer subject to file 2011-04-12 0

SHAFFER JAMES P EVP & CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2011-04-12 0

DOGWOOD HOLDING CORP.

  • 10% Owner
0 2011-03-25 0

FOREST LABORATORIES INC

FL HOLDING C.V. MANAGER

FLI INTERNATIONAL, LLC VICE PRESIDENT

MAGNOLIA ACQUISITION CORP. VICE PRESIDENT

  • Officer
  • 10% Owner
0 2011-02-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments